SCHEMBL6789600

SCHEMBL6789600

CCCCOc1ccc(N(C)CCC2(O)CCN(C(=O)Cc3ccc(F)cc3)CC2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.43
MMP1 P03956 1/20 0.41
MMP9 P14780 1/20 0.41
MMP13 P45452 1/20 0.41
HSD11B1 P28845 1/20 0.41
HRH2 P25021 1/20 0.41
HRH1 P35367 1/20 0.41
FAAH O00519 1/20 0.40
HTR2A P28223 1/20 0.40
POLB P06746 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
LTA4H P09960 1/20 0.39
KDM4E B2RXH2 2/20 0.39
GHSR Q92847 1/20 0.39
OPRM1 P35372 1/20 0.39
OPRD1 P41143 1/20 0.39
OPRK1 P41145 1/20 0.39
ME2 P23368 1/20 0.38
ME1 P48163 1/20 0.38
ME3 Q16798 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6783660 0.85 MMP1 (0.52) MMP1MMP9MMP13HRH3CYP2D6
Hydrochloric Acid SCHEMBL6783396 0.84 MMP1 (0.52) MMP1MMP9MMP13HRH3CYP2D6
SCHEMBL6791086 0.83 HTR2A (0.43) MMP1MMP9MMP13HRH1HTR2A
Hydrochloric Acid SCHEMBL6785753 0.82 HTR2A (0.42) MMP1MMP9MMP13HRH1HTR2A
SCHEMBL6789871 0.81 ALDH1A1 (0.46) MMP1MMP9MMP13HRH2HRH1
Hydrochloric Acid SCHEMBL6784250 0.81 ALDH1A1 (0.45) MMP1MMP9MMP13HRH2HRH1
SCHEMBL6786062 0.79 FAAH (0.50) L3MBTL1MMP1MMP9MMP13FAAH
SCHEMBL7223718 0.78 HRH3 (0.47) L3MBTL1POLBSMN1; SMN2KDM4EHRH3
SCHEMBL6784015 0.78 DRD2 (0.41) MMP1MMP9MMP13HRH1FAAH
SCHEMBL7228585 0.77 SMN1; SMN2 (0.51) L3MBTL1POLBSMN1; SMN2GHSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6710060-B2 4-hydroxypiperidine derivatives having antiarrhythmic activity MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2004-03-23 US disclosed
US-20020188006-A1 4-hydroxypiperidine derivatives having antiarrhythmic activity MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2002-12-12 US disclosed
EP-1182192-A1 4-HYDROXYPIPERIDINE DERIVATIVES HAVING ANTIARRHYTHMIC EFFECT MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2002-02-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020188006-A1 4-hydroxypiperidine derivatives having antiarrhythmic activity SCN5A, RYR2, SCN1B L3MBTL1 500/4885MMP1 1180/4885MMP9 1184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.